» Articles » PMID: 37238977

GM1 Oligosaccharide Efficacy in Parkinson's Disease: Protection Against MPTP

Abstract

Past evidence has shown that the exogenous administration of GM1 ganglioside slowed neuronal death in preclinical models of Parkinson's disease, a neurodegenerative disorder characterized by the progressive loss of dopamine-producing neurons: however, the physical and chemical properties of GM1 (i.e., amphiphilicity) limited its clinical application, as the crossing of the blood-brain barrier is denied. Recently, we demonstrated that the GM1 oligosaccharide head group (GM1-OS) is the GM1 bioactive portion that, interacting with the TrkA-NGF complex at the membrane surface, promotes the activation of a multivariate network of intracellular events regulating neuronal differentiation, protection, and reparation. Here, we evaluated the GM1-OS neuroprotective potential against the Parkinson's disease-linked neurotoxin MPTP, which destroys dopaminergic neurons by affecting mitochondrial bioenergetics and causing ROS overproduction. In dopaminergic and glutamatergic primary cultures, GM1-OS administration significantly increased neuronal survival, preserved neurite network, and reduced mitochondrial ROS production enhancing the mTOR/Akt/GSK3β pathway. These data highlight the neuroprotective efficacy of GM1-OS in parkinsonian models through the implementation of mitochondrial function and reduction in oxidative stress.

Citing Articles

GM1 Oligosaccharide Ameliorates Rett Syndrome Phenotypes In Vitro and In Vivo via Trk Receptor Activation.

Fazzari M, Lunghi G, Carsana E, Valsecchi M, Spiombi E, Breccia M Int J Mol Sci. 2024; 25(21).

PMID: 39519108 PMC: 11547101. DOI: 10.3390/ijms252111555.


GM1 ganglioside exerts protective effects against glutamate-excitotoxicity via its oligosaccharide in wild-type and amyotrophic lateral sclerosis motor neurons.

Lunghi G, Di Biase E, Carsana E, Henriques A, Callizot N, Mauri L FEBS Open Bio. 2023; 13(12):2324-2341.

PMID: 37885330 PMC: 10699117. DOI: 10.1002/2211-5463.13727.


Obatoclax Rescues FUS-ALS Phenotypes in iPSC-Derived Neurons by Inducing Autophagy.

Castillo Bautista C, Eismann K, Gentzel M, Pelucchi S, Mertens J, Walters H Cells. 2023; 12(18).

PMID: 37759469 PMC: 10527391. DOI: 10.3390/cells12182247.

References
1.
Fazzari M, Lunghi G, Chiricozzi E, Mauri L, Sonnino S . Gangliosides and the Treatment of Neurodegenerative Diseases: A Long Italian Tradition. Biomedicines. 2022; 10(2). PMC: 8962287. DOI: 10.3390/biomedicines10020363. View

2.
Ledeen R, Wu G . The multi-tasked life of GM1 ganglioside, a true factotum of nature. Trends Biochem Sci. 2015; 40(7):407-18. DOI: 10.1016/j.tibs.2015.04.005. View

3.
Gonzalez-Rodriguez P, Zampese E, Stout K, Guzman J, Ilijic E, Yang B . Disruption of mitochondrial complex I induces progressive parkinsonism. Nature. 2021; 599(7886):650-656. PMC: 9189968. DOI: 10.1038/s41586-021-04059-0. View

4.
Di Biase E, Lunghi G, Maggioni M, Fazzari M, Pome D, Loberto N . GM1 Oligosaccharide Crosses the Human Blood-Brain Barrier In Vitro by a Paracellular Route. Int J Mol Sci. 2020; 21(8). PMC: 7215935. DOI: 10.3390/ijms21082858. View

5.
Chiricozzi E, Maggioni M, Di Biase E, Lunghi G, Fazzari M, Loberto N . The Neuroprotective Role of the GM1 Oligosaccharide, IINeu5Ac-Gg, in Neuroblastoma Cells. Mol Neurobiol. 2019; 56(10):6673-6702. DOI: 10.1007/s12035-019-1556-8. View